These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16518340)

  • 21. Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors.
    Skibicka KP; Grill HJ
    Endocrinology; 2009 Apr; 150(4):1705-11. PubMed ID: 19056818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.
    do Carmo JM; da Silva AA; Rushing JS; Hall JE
    Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(5):R561-7. PubMed ID: 22204957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling.
    Mak RH; Cheung W
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):27-31. PubMed ID: 17143068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure.
    Scarlett JM; Bowe DD; Zhu X; Batra AK; Grant WF; Marks DL
    J Endocrinol; 2010 Jul; 206(1):121-30. PubMed ID: 20371568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal histamine regulates food intake, adiposity, and uncoupling protein expression in agouti yellow (A(y)/a) obese mice.
    Masaki T; Chiba S; Yoshimichi G; Yasuda T; Noguchi H; Kakuma T; Sakata T; Yoshimatsu H
    Endocrinology; 2003 Jun; 144(6):2741-8. PubMed ID: 12746338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
    Zhu X; Callahan MF; Gruber KA; Szumowski M; Marks DL
    J Clin Invest; 2020 Sep; 130(9):4921-4934. PubMed ID: 32544087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of food intake via leptin receptors in the hypothalamus.
    Meister B
    Vitam Horm; 2000; 59():265-304. PubMed ID: 10714243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of central leptin signaling in renal macrophage infiltration.
    Tanaka M; Suganami T; Sugita S; Shimoda Y; Kasahara M; Aoe S; Takeya M; Takeda S; Kamei Y; Ogawa Y
    Endocr J; 2010; 57(1):61-72. PubMed ID: 19851035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin and the pituitary.
    Sone M; Osamura RY
    Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects of leptin.
    Sinha MK; Caro JF
    Vitam Horm; 1998; 54():1-30. PubMed ID: 9529971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leptin: regulatory role in bone metabolism and in inflammation].
    De Marchi G; Ferraccioli G
    Reumatismo; 2002; 54(3):217-25. PubMed ID: 12404029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the central melanocortin system in cachexia.
    Marks DL; Ling N; Cone RD
    Cancer Res; 2001 Feb; 61(4):1432-8. PubMed ID: 11245447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.
    Havel PJ
    Curr Opin Lipidol; 2002 Feb; 13(1):51-9. PubMed ID: 11790963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.
    Dallmann R; Weyermann P; Anklin C; Boroff M; Bray-French K; Cardel B; Courdier-Fruh I; Deppe H; Dubach-Powell J; Erb M; Haefeli RH; Henneböhle M; Herzner H; Hufschmid M; Marks DL; Nordhoff S; Papp M; Rummey C; Santos G; Schärer F; Siendt H; Soeberdt M; Sumanovski LT; Terinek M; Mondadori C; Güven N; Feurer A
    J Cachexia Sarcopenia Muscle; 2011 Sep; 2(3):163-174. PubMed ID: 21966642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
    Hoggard N; Rayner DV; Johnston SL; Speakman JR
    J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanocortins and reproduction.
    Schiöth HB; Watanobe H
    Brain Res Brain Res Rev; 2002 Feb; 38(3):340-50. PubMed ID: 11890981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
    Moussa NM; Claycombe KJ
    Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychiatric disorders and neural mechanisms underlying energy intake and expenditure: a review].
    Kishi T; Horiguchi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):197-203. PubMed ID: 14653225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms mediating renal sympathetic activation to leptin in obesity.
    Morgan DA; Thedens DR; Weiss R; Rahmouni K
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1730-6. PubMed ID: 18815209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appetite control and reproduction: leptin and beyond.
    Small CJ; Stanley SA; Bloom SR
    Semin Reprod Med; 2002 Nov; 20(4):389-98. PubMed ID: 12536362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.